Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Growth 2026-2032
The global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine players cover Pfizer, Kangtai, Walvax Biotechnology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Industry Forecast” looks at past sales and reviews total world 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine sales for 2026 through 2032. With 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine industry.
This Insight Report provides a comprehensive analysis of the global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
United States market for 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine players cover Pfizer, Kangtai, Walvax Biotechnology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Industry Forecast” looks at past sales and reviews total world 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine sales for 2026 through 2032. With 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine industry.
This Insight Report provides a comprehensive analysis of the global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Vials
- Pre-filled
- Hospital
- Clinic
- CDC
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Kangtai
- Walvax Biotechnology
- What is the 10-year outlook for the global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine market?
- What factors are driving 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine market opportunities vary by end market size?
- How does 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine by Country/Region, 2021, 2025 & 2032
2.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Segment by Type
2.2.1 Vials
2.2.2 Pre-filled
2.2.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Type
2.2.3.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sale Price by Type (2021-2026)
2.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 CDC
2.3.4 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Application
2.3.4.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sale Market Share by Application (2021-2026)
2.3.4.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Breakdown Data by Company
3.1.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Company (2021-2026)
3.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue by Company (2021-2026)
3.2.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sale Price by Company
3.4 Key Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Product Location Distribution
3.4.2 Players 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR 13-VALENT PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Growth
4.4 APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Growth
4.5 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Growth
4.6 Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Growth
5 AMERICAS
5.1 Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Country
5.1.1 Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Country (2021-2026)
5.1.2 Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue by Country (2021-2026)
5.2 Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Type (2021-2026)
5.3 Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Region
6.1.1 APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Region (2021-2026)
6.1.2 APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue by Region (2021-2026)
6.2 APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Type (2021-2026)
6.3 APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine by Country
7.1.1 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Country (2021-2026)
7.1.2 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue by Country (2021-2026)
7.2 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Type (2021-2026)
7.3 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine by Country
8.1.1 Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine
10.3 Manufacturing Process Analysis of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine
10.4 Industry Chain Structure of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Distributors
11.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Customer
12 WORLD FORECAST REVIEW FOR 13-VALENT PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE BY GEOGRAPHIC REGION
12.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Size Forecast by Region
12.1.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Forecast by Region (2027-2032)
12.1.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Forecast by Type (2027-2032)
12.7 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Product Portfolios and Specifications
13.1.3 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Kangtai
13.2.1 Kangtai Company Information
13.2.2 Kangtai 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Product Portfolios and Specifications
13.2.3 Kangtai 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Kangtai Main Business Overview
13.2.5 Kangtai Latest Developments
13.3 Walvax Biotechnology
13.3.1 Walvax Biotechnology Company Information
13.3.2 Walvax Biotechnology 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Product Portfolios and Specifications
13.3.3 Walvax Biotechnology 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Walvax Biotechnology Main Business Overview
13.3.5 Walvax Biotechnology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine by Country/Region, 2021, 2025 & 2032
2.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Segment by Type
2.2.1 Vials
2.2.2 Pre-filled
2.2.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Type
2.2.3.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sale Price by Type (2021-2026)
2.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 CDC
2.3.4 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Application
2.3.4.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sale Market Share by Application (2021-2026)
2.3.4.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Breakdown Data by Company
3.1.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Company (2021-2026)
3.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue by Company (2021-2026)
3.2.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sale Price by Company
3.4 Key Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Product Location Distribution
3.4.2 Players 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR 13-VALENT PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Growth
4.4 APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Growth
4.5 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Growth
4.6 Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Growth
5 AMERICAS
5.1 Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Country
5.1.1 Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Country (2021-2026)
5.1.2 Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue by Country (2021-2026)
5.2 Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Type (2021-2026)
5.3 Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Region
6.1.1 APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Region (2021-2026)
6.1.2 APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue by Region (2021-2026)
6.2 APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Type (2021-2026)
6.3 APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine by Country
7.1.1 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Country (2021-2026)
7.1.2 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue by Country (2021-2026)
7.2 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Type (2021-2026)
7.3 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine by Country
8.1.1 Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine
10.3 Manufacturing Process Analysis of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine
10.4 Industry Chain Structure of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Distributors
11.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Customer
12 WORLD FORECAST REVIEW FOR 13-VALENT PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE BY GEOGRAPHIC REGION
12.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Size Forecast by Region
12.1.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Forecast by Region (2027-2032)
12.1.2 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Forecast by Type (2027-2032)
12.7 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Product Portfolios and Specifications
13.1.3 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Kangtai
13.2.1 Kangtai Company Information
13.2.2 Kangtai 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Product Portfolios and Specifications
13.2.3 Kangtai 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Kangtai Main Business Overview
13.2.5 Kangtai Latest Developments
13.3 Walvax Biotechnology
13.3.1 Walvax Biotechnology Company Information
13.3.2 Walvax Biotechnology 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Product Portfolios and Specifications
13.3.3 Walvax Biotechnology 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Walvax Biotechnology Main Business Overview
13.3.5 Walvax Biotechnology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Vials
Table 4. Major Players of Pre-filled
Table 5. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Type (2021-2026) & (K Units)
Table 6. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sale by Application (2021-2026) & (K Units)
Table 11. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Company (2021-2026) & (K Units)
Table 16. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Producing Area Distribution and Sales Area
Table 21. Players 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Products Offered
Table 22. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Country (2021-2026) & (K Units)
Table 34. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Type (2021-2026) & (K Units)
Table 37. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Application (2021-2026) & (K Units)
Table 38. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Region (2021-2026) & (K Units)
Table 39. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Type (2021-2026) & (K Units)
Table 42. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Application (2021-2026) & (K Units)
Table 43. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Country (2021-2026) & (K Units)
Table 44. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine
Table 52. Key Market Challenges & Risks of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine
Table 53. Key Industry Trends of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine
Table 54. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Distributors List
Table 57. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Customer List
Table 58. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Pfizer Basic Information, 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Product Portfolios and Specifications
Table 74. Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Pfizer Main Business
Table 76. Pfizer Latest Developments
Table 77. Kangtai Basic Information, 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Kangtai 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Product Portfolios and Specifications
Table 79. Kangtai 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Kangtai Main Business
Table 81. Kangtai Latest Developments
Table 82. Walvax Biotechnology Basic Information, 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Walvax Biotechnology 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Product Portfolios and Specifications
Table 84. Walvax Biotechnology 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Walvax Biotechnology Main Business
Table 86. Walvax Biotechnology Latest Developments
Table 1. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Vials
Table 4. Major Players of Pre-filled
Table 5. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Type (2021-2026) & (K Units)
Table 6. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sale by Application (2021-2026) & (K Units)
Table 11. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Company (2021-2026) & (K Units)
Table 16. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Producing Area Distribution and Sales Area
Table 21. Players 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Products Offered
Table 22. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Country (2021-2026) & (K Units)
Table 34. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Type (2021-2026) & (K Units)
Table 37. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Application (2021-2026) & (K Units)
Table 38. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Region (2021-2026) & (K Units)
Table 39. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Type (2021-2026) & (K Units)
Table 42. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Application (2021-2026) & (K Units)
Table 43. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Country (2021-2026) & (K Units)
Table 44. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine
Table 52. Key Market Challenges & Risks of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine
Table 53. Key Industry Trends of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine
Table 54. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Distributors List
Table 57. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Customer List
Table 58. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Pfizer Basic Information, 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Product Portfolios and Specifications
Table 74. Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Pfizer Main Business
Table 76. Pfizer Latest Developments
Table 77. Kangtai Basic Information, 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Kangtai 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Product Portfolios and Specifications
Table 79. Kangtai 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Kangtai Main Business
Table 81. Kangtai Latest Developments
Table 82. Walvax Biotechnology Basic Information, 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Walvax Biotechnology 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Product Portfolios and Specifications
Table 84. Walvax Biotechnology 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Walvax Biotechnology Main Business
Table 86. Walvax Biotechnology Latest Developments
LIST OF FIGURES
Figure 1. Picture of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine
Figure 2. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Country/Region (2025)
Figure 10. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Vials
Figure 12. Product Picture of Pre-filled
Figure 13. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Type in 2026
Figure 14. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumed in Hospital
Figure 16. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market: Hospital (2021-2026) & (K Units)
Figure 17. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumed in Clinic
Figure 18. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market: Clinic (2021-2026) & (K Units)
Figure 19. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumed in CDC
Figure 20. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market: CDC (2021-2026) & (K Units)
Figure 21. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sale Market Share by Application (2025)
Figure 22. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Market Share by Application in 2026
Figure 23. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Company in 2026 (K Units)
Figure 24. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Company in 2026
Figure 25. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue by Company in 2026 ($ millions)
Figure 26. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Market Share by Company in 2026
Figure 27. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Market Share by Geographic Region in 2026
Figure 29. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales 2021-2026 (K Units)
Figure 30. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue 2021-2026 ($ millions)
Figure 31. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales 2021-2026 (K Units)
Figure 32. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales 2021-2026 (K Units)
Figure 34. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue 2021-2026 ($ millions)
Figure 37. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Country in 2026
Figure 38. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Market Share by Country (2021-2026)
Figure 39. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Type (2021-2026)
Figure 40. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Application (2021-2026)
Figure 41. United States 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Region in 2026
Figure 46. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Market Share by Region (2021-2026)
Figure 47. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Type (2021-2026)
Figure 48. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Application (2021-2026)
Figure 49. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. India 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Country in 2026
Figure 57. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Market Share by Country (2021-2026)
Figure 58. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Type (2021-2026)
Figure 59. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Application (2021-2026)
Figure 60. Germany 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. France 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. UK 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Application (2021-2026)
Figure 68. Egypt 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine in 2026
Figure 74. Manufacturing Process Analysis of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine
Figure 75. Industry Chain Structure of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine
Figure 76. Channels of Distribution
Figure 77. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Forecast by Region (2027-2032)
Figure 78. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine
Figure 2. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Country/Region (2025)
Figure 10. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Vials
Figure 12. Product Picture of Pre-filled
Figure 13. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Type in 2026
Figure 14. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumed in Hospital
Figure 16. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market: Hospital (2021-2026) & (K Units)
Figure 17. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumed in Clinic
Figure 18. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market: Clinic (2021-2026) & (K Units)
Figure 19. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumed in CDC
Figure 20. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market: CDC (2021-2026) & (K Units)
Figure 21. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sale Market Share by Application (2025)
Figure 22. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Market Share by Application in 2026
Figure 23. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales by Company in 2026 (K Units)
Figure 24. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Company in 2026
Figure 25. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue by Company in 2026 ($ millions)
Figure 26. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Market Share by Company in 2026
Figure 27. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Market Share by Geographic Region in 2026
Figure 29. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales 2021-2026 (K Units)
Figure 30. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue 2021-2026 ($ millions)
Figure 31. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales 2021-2026 (K Units)
Figure 32. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales 2021-2026 (K Units)
Figure 34. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue 2021-2026 ($ millions)
Figure 37. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Country in 2026
Figure 38. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Market Share by Country (2021-2026)
Figure 39. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Type (2021-2026)
Figure 40. Americas 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Application (2021-2026)
Figure 41. United States 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Region in 2026
Figure 46. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Market Share by Region (2021-2026)
Figure 47. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Type (2021-2026)
Figure 48. APAC 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Application (2021-2026)
Figure 49. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. India 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Country in 2026
Figure 57. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Market Share by Country (2021-2026)
Figure 58. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Type (2021-2026)
Figure 59. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Application (2021-2026)
Figure 60. Germany 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. France 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. UK 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share by Application (2021-2026)
Figure 68. Egypt 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine in 2026
Figure 74. Manufacturing Process Analysis of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine
Figure 75. Industry Chain Structure of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine
Figure 76. Channels of Distribution
Figure 77. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Forecast by Region (2027-2032)
Figure 78. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Revenue Market Share Forecast by Application (2027-2032)
